Sprouts Farmers Market is a high-quality specialty grocer with double-digit revenue growth, industry-leading margins, and disciplined capital allocation. SFM operates more like a growth retailer than a conventional supermarket, achieving 39% gross margins and a 31% EPS CAGR over three years. Despite a premium valuation (17x trailing earnings), SFM's PEG ratio of ~1.0 reflects earnings growth that justifies its multiple.

Sprouts Farmers (SFM) closed at $86.7 in the latest trading session, marking a +2.51% move from the prior day.

PHOENIX--(BUSINESS WIRE)--Sprouts Farmers Market, Inc. (Nasdaq: SFM) today announced it will issue financial results for the second quarter ended June 28, 2026 after the market closes on Wednesday, July 29, 2026. Following the release, Sprouts' management will conduct a conference call at 5:00 p.m. ET to discuss the results for the quarter. A webcast of the conference call will be available at investors.sprouts.com. Participants should register on the website approximately ten minutes prior to.

On June 25, 2026, Sprouts Farmers Market Inc (SFM) shares fell 3.9% today, bringing the current price to $82.05. The stock's 52-week range has seen a high of $1

In the closing of the recent trading day, Sprouts Farmers (SFM) stood at $85.38, denoting a +1.03% move from the preceding trading day.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Sprouts Farmers (SFM) closed the most recent trading day at $83.61, moving 2.08% from the previous trading session.

These three stocks are down between 50% and 58% from their 52-week highs. All three are leaders of their respective niches but have seen sales growth slow recently.

Beyond Meat, Sprouts Farmers and United Natural Foods are in focus as health-conscious consumers fuel demand for organic, clean-label and ethically sourced foods.

Scott Galloway and Ed Elson laid out the math on Prof G Markets and it should make every fast food shareholder uneasy: roughly 30 million Americans, about 1 in 8 US adults, are now on GLP-1s, and the drugs are reducing fast food's addressable market by an estimated 27-30%.